HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lorenzo Belluomini Selected Research

Lorenzo Belluomini Research Topics

Disease

14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 11/2018
13Neoplasms (Cancer)
04/2024 - 11/2019
10Lung Neoplasms (Lung Cancer)
03/2024 - 11/2018
2Breast Neoplasms (Breast Cancer)
03/2024 - 09/2023
2Infections
01/2024 - 12/2020
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2023 - 10/2022
2Inflammation (Inflammations)
01/2023 - 11/2021
2Adenocarcinoma of Lung
08/2022 - 01/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
11/2023
1Melanoma (Melanoma, Malignant)
09/2023
1Disease Progression
08/2022
1Adenocarcinoma
01/2022
1Post-Acute COVID-19 Syndrome
01/2022
1Lung Diseases (Lung Disease)
08/2021
1Cachexia
01/2021
1Death (Near-Death Experience)
01/2021
1Virus Diseases (Viral Diseases)
12/2020
1COVID-19
12/2020
1Hepatitis B
12/2020
1Communicable Diseases (Infectious Diseases)
12/2020
1Bacterial Infections (Bacterial Infection)
12/2020
1Dysbiosis
12/2020
1Stomach Neoplasms (Stomach Cancer)
02/2018

Drug/Important Bio-Agent (IBA)

5pembrolizumabIBA
03/2024 - 06/2019
5Immune Checkpoint InhibitorsIBA
11/2023 - 11/2018
5NivolumabIBA
01/2023 - 11/2018
3PlatinumIBA
03/2024 - 01/2020
3Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2022
2Pemetrexed (MTA)FDA Link
03/2024 - 01/2022
2Immunoconjugates (Immunoconjugate)IBA
11/2023 - 04/2023
2LigandsIBA
11/2023 - 06/2019
2Hormones (Hormone)IBA
09/2023 - 11/2021
2Tyrosine Kinase InhibitorsIBA
04/2023 - 01/2022
2Cell-Free Nucleic AcidsIBA
08/2022 - 06/2021
2ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2022
1Carboplatin (JM8)FDA LinkGeneric
03/2024
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2024
1VaccinesIBA
01/2024
1sacituzumab govitecanIBA
11/2023
1Imatinib Mesylate (Gleevec)FDA Link
09/2023
1osimertinibIBA
09/2023
1Surface Antigens (Surface Antigen)IBA
04/2023
1RNA (Ribonucleic Acid)IBA
08/2022
1selpercatinibIBA
01/2022
1SmokeIBA
01/2022
1GoldIBA
01/2022
1Messenger RNA (mRNA)IBA
06/2021
1Anti-Bacterial Agents (Antibiotics)IBA
12/2020
1AfatinibIBA
01/2020
1durvalumabIBA
06/2019
1atezolizumabIBA
06/2019
1Programmed Cell Death 1 ReceptorIBA
06/2019
1Trastuzumab (Herceptin)FDA Link
02/2018

Therapy/Procedure

11Therapeutics
03/2024 - 11/2019
7Immunotherapy
03/2024 - 11/2019
4Radiotherapy
01/2022 - 11/2018
3Preoperative Exercise
04/2024 - 08/2021
2Precision Medicine
01/2022 - 01/2021
2Drug Therapy (Chemotherapy)
01/2022 - 01/2020
1Length of Stay
04/2024
1Resistance Training
03/2024
1Immunomodulation
01/2022
1Preoperative Period
08/2021